Managing diabetes

According to the International Diabetes Federation (IDF), 366 million people worldwide have diabetes, with numbers expected to increase to 552 million people by 2030. It is also estimated that for every three people with diabetes, one person remains undiagnosed.

“Italian Barometer Diabetes Report 2015”


The main problems to be addressed in this context are chronic complications and acute episodes that lead to hospitalisation, as well as the risk of developing co-morbidity. The national health service spends 15 billion Euros each year on treating people with diabetes, in addition to the three billion Euros that individuals take out of their own pocket. It has therefore become essential to spread a culture of prevention of complications in both the short and long term, which is closely related to a person’s degree of glycaemic self-control.

Our Solutions

The Continuous Glucose Monitoring system (CGM) is therefore of notable importance. This system allows for the more effective and efficient adjustment of therapy and the implementation of preventive operations and corrective measures, in order to maintain or restore glycaemia to a normal physiological range and to prevent complications in the short and long term.


Omnipod® System a tubeless, waterproof insulin pump designed to manage insulin-dependent diabetes. It is made up of two components: a tubeless pod and the handheld Personal Diabetes Manager (PDM) to be kept at hand to set up wirelessly insulin delivery.

Dexcom G6®

Continuous Glucose Monitoring system (CGM) is a method to manage diabetes by tracking real-time glucose levels (24 hours a day), thanks to a sensor positioned just under your skin.

G5 Mobile

The first continuous glucose monitoring system (CGM) to require no withdrawals from the fingertip in order to confirm treatment decisions (FDA approved to make treatment decisions). Dexcom G5 is also approved for use with children aged two years and up.

Click to open Popup Click to open Popup